The document is a series of 25 sections from the blog "Next in Security" by Ing. Sijmen Ruwhof discussing various topics relating to security. Each section is dated May 11, 2011 and numbered. The sections discuss concerns over security, how things could be worse, and asking where one's worries come from.
The document is a series of 25 sections from the blog "Next in Security" by Ing. Sijmen Ruwhof discussing various topics relating to security. Each section is dated May 11, 2011 and numbered. The sections discuss concerns over security, how things could be worse, and asking where one's worries come from.
Health and fitness apps and devices collect users' personal data, but it is unclear how user data is monetized and who earns from it. A proposed solution is a personal health record platform with an open app store that crowd-sources app development and takes a percentage of app store revenues, while providing platform-level privacy and easy data access. This could form the basis of a new business model for personal health and healthcare data.
This document discusses using ELISA without washing steps by developing a switchable reporter enzyme system. It describes tuning a beta-lactamase enzyme and its inhibitor protein to have high affinity binding and then using this system for wash-free ELISA assays. The goal is to create assays that are faster and require less hands-on time by eliminating washing steps traditionally required in ELISA.
Jack Schalken has co-founded two companies - NovioGendix in 2006 and Oncodrone in 2013 - to translate his translational research into clinical applications and products. As an "entrepreneurial scientist", he learned important lessons about negotiating terms with his academic institution, building a management team, securing financing, and acquiring business skills to successfully launch and grow these ventures. Both companies have worked to bridge the gap between research and clinical validation or product development for cancer diagnostics and therapeutics.
Workshop Co-creatie in de zorg: Embedded Field labsHealth Valley
Presentatie over Embedded Fieldlabs van Dorine Pluimers en Greetje de Kleuver op het Health Valley Event 2014 tijdens de workshop Co-creatie in de zorg.
Health and fitness apps and devices collect users' personal data, but it is unclear how user data is monetized and who earns from it. A proposed solution is a personal health record platform with an open app store that crowd-sources app development and takes a percentage of app store revenues, while providing platform-level privacy and easy data access. This could form the basis of a new business model for personal health and healthcare data.
This document discusses using ELISA without washing steps by developing a switchable reporter enzyme system. It describes tuning a beta-lactamase enzyme and its inhibitor protein to have high affinity binding and then using this system for wash-free ELISA assays. The goal is to create assays that are faster and require less hands-on time by eliminating washing steps traditionally required in ELISA.
Jack Schalken has co-founded two companies - NovioGendix in 2006 and Oncodrone in 2013 - to translate his translational research into clinical applications and products. As an "entrepreneurial scientist", he learned important lessons about negotiating terms with his academic institution, building a management team, securing financing, and acquiring business skills to successfully launch and grow these ventures. Both companies have worked to bridge the gap between research and clinical validation or product development for cancer diagnostics and therapeutics.
Workshop Co-creatie in de zorg: Embedded Field labsHealth Valley
Presentatie over Embedded Fieldlabs van Dorine Pluimers en Greetje de Kleuver op het Health Valley Event 2014 tijdens de workshop Co-creatie in de zorg.
3. Events
17 – 20 november Medica Düsseldorf
29 – 30 november Medicine 2.0 Maastricht
2 december Medisch Netwerk Nijmegen Nijmegen
‘Verandering in zorgverlening’
5. Einde plenaire gedeelte
Wij nodigen u uit voor onze parallelsessies:
Sessie A Medical imaging/LEO Zaal 7
Sessie B Moleculaire Diagnostiek Zaal 6
Sessie C High Tech Health Farm Zaal 5
Sessie D Biomaterialen/tissue engineering Zaal 8